AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $365 | +2.2% | 5,229 | +5.2% | 0.00% | 0.0% |
| Q2 2023 | $357 | +28.0% | 4,972 | +9.8% | 0.00% | +50.0% |
| Q1 2023 | $279 | -31.4% | 4,529 | -14.2% | 0.00% | -50.0% |
| Q4 2022 | $407 | -99.8% | 5,279 | +9.7% | 0.00% | +100.0% |
| Q3 2022 | $215,000 | +23.6% | 4,812 | +5.7% | 0.00% | 0.0% |
| Q2 2022 | $174,000 | -7.0% | 4,551 | +0.6% | 0.00% | +100.0% |
| Q1 2022 | $187,000 | -47.2% | 4,525 | -13.8% | 0.00% | -66.7% |
| Q2 2021 | $354,000 | +58.7% | 5,248 | +33.2% | 0.00% | -62.5% |
| Q1 2021 | $223,000 | -36.8% | 3,940 | -9.0% | 0.01% | -38.5% |
| Q4 2020 | $353,000 | +15.0% | 4,332 | +0.5% | 0.01% | 0.0% |
| Q3 2020 | $307,000 | -15.9% | 4,310 | -2.8% | 0.01% | -23.5% |
| Q2 2020 | $365,000 | +33.7% | 4,433 | -4.4% | 0.02% | +142.9% |
| Q1 2020 | $273,000 | -42.4% | 4,635 | +1.0% | 0.01% | -22.2% |
| Q4 2019 | $474,000 | – | 4,588 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |